GAS2L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.082400E-01
Normal-vs-Stage2
3.409800E-01
Normal-vs-Stage3
3.345800E-01
Normal-vs-Stage4
2.733400E-01
Stage1-vs-Stage2
5.720000E-01
Stage1-vs-Stage3
2.289600E-01
Stage1-vs-Stage4
5.602600E-01
Stage2-vs-Stage3
6.972000E-04
Stage2-vs-Stage4
9.245400E-01
Stage3-vs-Stage4
7.237800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.895200E-01
Normal-vs-AfricanAmerican
3.101400E-01
Normal-vs-Asian
5.815600E-01
Caucasian-vs-AfricanAmerican
3.538000E-01
Caucasian-vs-Asian
7.135000E-01
AfricanAmerican-vs-Asian
2.177600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.638000E-01
Normal-vs-Female
4.275600E-01
Male-vs-Female
9.127800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.681000E-01
Normal-vs-Age(41-60Yrs)
2.590000E-01
Normal-vs-Age(61-80Yrs)
4.287000E-01
Normal-vs-Age(81-100Yrs)
5.622000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.599200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.177600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.486600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.598200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.792800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.628800E-01
Normal-vs-Daily Drinker
8.369200E-01
Normal-vs-Weekly Drinker
4.957200E-01
Normal-vs-Occasional Drinker
4.068200E-01
Normal-vs-Social Drinker
2.682600E-01
Non Drinker-vs-Daily Drinker
4.945700E-02
Non Drinker-vs-Weekly Drinker
7.397800E-01
Non Drinker-vs-Occasional Drinker
9.819400E-01
Non Drinker-vs-Social Drinker
4.988400E-01
Daily Drinker-vs-Weekly Drinker
2.059800E-01
Daily Drinker-vs-Occasional Drinker
1.178840E-01
Daily Drinker-vs-Social Drinker
4.385500E-02
Weekly Drinker-vs-Occasional Drinker
7.504400E-01
Weekly Drinker-vs-Social Drinker
9.118800E-01
Occasional Drinker-vs-Social Drinker
5.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
9.807000E-01
Grade 1-vs-Grade 3
6.096600E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
3.899400E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.707200E-01
Normal-vs-NonDiabetic
3.914800E-01
Diabetic-vs-NonDiabetic
8.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.561200E-01
Normal-vs-NoPancreatitis
4.267600E-01
Pancreatitis-vs-NoPancreatitis
9.155400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.653600E-01
Normal-vs-N1
3.295000E-01
N0-vs-N1
9.468600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.206200E-01
Normal-vs-TP53-NonMutant
1.039740E-02
TP53-Mutant-vs-TP53-NonMutant
2.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
